The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Evaluation of a Unique Oral Contraceptive in the Treatment of Premenstrual Dysphoric Disorder
Abstract
Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome (PMS). This is the first trial of a unique oral contraceptive containing a combination of drospirenone (DRSP, 3 mg) and ethinyl estradiol (EE, 30 microg) for the treatment of PMDD. DRSP is a spironolactone-like progestin with antiandrogenic and antimineralocorticoid activity. Spironolactone has been shown to be beneficial in PMS, whereas oral contraceptives have shown conflicting results. In this double-blind, placebo-controlled trial, 82 women with PMDD (Diagnostic and Statistical Manual of Mental Disorders, 4th ed. [DSM IV]) were randomized to receive DRSP/EE or placebo for three treatment cycles. The primary end point was change from baseline in luteal phase symptom scores as assessed on the Calendar of Premenstrual Experiences (COPE) scale. Patients treated with DRSP/EE showed a numerically greater change from baseline compared with those treated with placebo on each of the 22 COPE items and each of the 4 symptom factors. Between-group differences in symptom improvement reached statistical significance in factor 3 only (appetite, acne, and food cravings, p = 0.027). The secondary end points, Beck Depression Inventory (BDI) and Profile of Mood States (PMS), were consistent with the primary end point in that patients treated with the oral contraceptive showed a numerically greater improvement from baseline compared with those treated with placebo. The results of this study show a consistent trend in the reduction of symptoms that suggested a beneficial effect of DRSP/EE for the treatment of PMDD, despite limitations of the study design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams, L. F., & Rubinow, D. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380401 · Cited by 765
Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review
Dimmock, P. W., Wyatt, K. M., Jones, P. W., & O'Brien, P. S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02754-9 · Cited by 368 · cited 1×
“40 These data and other studies in which PMDD symptoms are affected by stimulation of the serotonin system with fen-fluramine 41 or depletion of serotonin with a tryptophan depletion diet 42 suggest that serotonin levels also play an important role in the pathophysiology of PMDD.”
Cited by
The premenstrual symptoms screening tool (PSST) for clinicians
Steiner, M., Macdougall, M., & Brown, E. (2003) · Archives of Women's Mental Health · doi:10.1007/s00737-003-0018-4 · Cited by 641
Soares, C. N., & Zitek, B. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0831 · Cited by 350
Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric Disorder
Yonkers, K. A., Brown, C., Pearlstein, T. B., Foegh, M., Sampson-Landers, C., & Rapkin, A. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000175834.77215.2e · Cited by 349
Self-citationCombined oral contraceptive pills for treatment of acne
Arowojolu, A. O., Gallo, M. F., Lopez, L. M., & Grimes, D. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004425.pub6 · Cited by 308
Premenstrual Syndrome and Premenstrual Dysphoric Disorder
Braverman, P. K. (2007) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2006.10.007 · Cited by 288
Metadata
- Authors
- Freeman, E. W., Kroll, R., Rapkin, A., Pearlstein, T., Brown, C., Parsey, K., Zhang, P., Patel, H., & Foegh, M.
- Venue
- Journal of Women's Health & Gender-Based Medicine
- Publisher
- SAGE Publications
- Published
- 2001-07
- Volume
- 10
- Issue
- 6
- Pages
- 561-569
- ISSN
- 1524-6094 (ISSN-L)
- OpenAlex
- W1988353419
- Cited by
- 163
- References
- 2
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of a Unique Oral Contraceptive in the Treatment of Premenstrual Dysphoric Disorder. https://app.cochat.ai/papers/10.1089/15246090152543148
- The paper
- Freeman, E. W., Kroll, R., Rapkin, A., Pearlstein, T., Brown, C., Parsey, K., Zhang, P., Patel, H., & Foegh, M. (2001). Evaluation of a Unique Oral Contraceptive in the Treatment of Premenstrual Dysphoric Disorder. Journal of Women's Health & Gender-Based Medicine. https://doi.org/10.1089/15246090152543148
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.